NEW YORK -- Wound care products used to treat traumatic injury and surgical wounds will garner revenues in excess of $4.3 billion in 2003, according to a new study released today by Kalorama Information. Although these wound types represent over half of the total wound care market, the impressive gains of the past few years will be slowing.
The study, "Wound Care Markets Volume III: Surgical and Trauma Wounds," revealed that wound closure devices continue to dominate the segment. However, the explosive growth displayed by the newer technologies in wound closure, such as adhesives and sealants -- which was a major driver for the segment -- will slow significantly over the next five years. Likewise, the biological dressings segment, parts of which showed greater than 35 percent compound annual growth in the past few years, should also fall in line with the rest of wound markets by 2005.
"The introduction of novel closure methods and growth factors have had their impact," notes Steven Heffner, acquisitions editor for Kalorama Information. "Although many are still predicting a rosy market scenario, we think the next wave of technologies is a few years off and that the coming five years will be a time of maturation in the marketplace."
The study analyzes the world market for products used in surgical and trauma wounds including sutures, staples, adhesives, and sealants; anti-infective products; cleansing, debridement, tapes, and dry dressings; moist dressings, such as alginates, hydrocolloids, hydrogels, films, and foams; biological products such as artificial skin, collagen, and growth factor; and other treatments. The study represents the third and final volume in a seven-month study of wound care markets by specific indication. The previous two volumes looked at the skin ulcer and burn segments, respectively.
Kalorama Information, an imprint of MarketResearch.com, supplies the latest in independent market research for the life sciences.
Source: MarketResearch.com
Hiding in Plain Sight: The Most Harmful and Costly Hospital-Acquired Infection
February 5th 2025Nonventilator hospital-acquired pneumonia (NV-HAP) is a deadly, overlooked infection impacting patient outcomes. With new diagnostic tools and prevention strategies, hospitals must prioritize oral hygiene to reduce risk.
The Hidden Dangers of Hospital Ventilation: Are We Spreading Viruses Further?
January 31st 2025New research reveals hospital ventilation and air purifiers may unintentionally spread viral particles, increasing infection risks. Infection preventionists must rethink airflow strategies to protect patients and staff.
Alcohol-Based Antiseptics Show Promise for Nasal Decolonization and SSI Prevention
January 23rd 2025A meta-analysis found alcohol-based antiseptics significantly reduce Staphylococcus aureus-related surgical site infections (SSIs), demonstrating efficacy comparable to mupirocin and iodophor, supporting their expanded use in infection prevention strategies.
Top 7 Infection Control Today Articles of 2024: Insights and Innovations
December 30th 2024From advanced sterilization methods to combating antimicrobial resistance, Infection Control Today’s top articles of 2024 delivered actionable strategies for safer healthcare environments and improved patient outcomes.
Understanding NHSN's 2022 Rebaseline Data: Key Updates and Implications for HAI Reporting
December 13th 2024Discover how the NHSN 2022 Rebaseline initiative updates health care-associated infection metrics to align with modern health care trends, enabling improved infection prevention strategies and patient safety outcomes.